Corrigendum: Abscopal Effects in Radio-Immunotherapy—Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition

• Maike Trommer,
• Maike Trommer,
• Maike Trommer,
• Sin Yuin Yeo,
• Sin Yuin Yeo,
• Thorsten Persigehl,
• Thorsten Persigehl,
• Anne Bunck,
• Anne Bunck,
• Holger Grüll,
• Holger Grüll,
• Max Schlaak,
• Max Schlaak,
• Sebastian Theurich,
• Sebastian Theurich,
• Sebastian Theurich,
• Michael von Bergwelt-Baildon,
• Michael von Bergwelt-Baildon,
• Janis Morgenthaler,
• Janis Morgenthaler,
• Jan M. Herter,
• Jan M. Herter,
• Jan M. Herter,
• Eren Celik,
• Eren Celik,
• Simone Marnitz,
• Simone Marnitz,
• Simone Marnitz,
• Christian Baues,
• Christian Baues,
• Christian Baues

Affiliations

Maike Trommer

Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany

Maike Trommer

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Maike Trommer

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Sin Yuin Yeo

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Sin Yuin Yeo

Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany

Thorsten Persigehl

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Thorsten Persigehl

Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany

Anne Bunck

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Anne Bunck

Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany

Holger Grüll

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Holger Grüll

Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University of Cologne, Cologne, Germany

Max Schlaak

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Max Schlaak

Department of Dermatology and Allergology, Ludwig-Maximilians University Munich, Munich, Germany

Sebastian Theurich

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Sebastian Theurich

Department of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany

Sebastian Theurich

Gene Center, Cancer- and Immunometabolism Research Group, Ludwig-Maximilians University Munich, Munich, Germany

Michael von Bergwelt-Baildon

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Michael von Bergwelt-Baildon

Department of Medicine III, University Hospital, Ludwig-Maximilians University Munich, Munich, Germany

Janis Morgenthaler

Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany

Janis Morgenthaler

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Jan M. Herter

Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany

Jan M. Herter

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Jan M. Herter

Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany

Eren Celik

Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany

Eren Celik

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Simone Marnitz

Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany

Simone Marnitz

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Simone Marnitz

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany

Christian Baues

Faculty of Medicine and University Hospital Cologne, Department of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany

Christian Baues

Faculty of Medicine and University Hospital Cologne, Radio Immune-Oncology Consortium, University of Cologne, Cologne, Germany

Christian Baues

Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology (CIO Köln Bonn), University of Cologne, Cologne, Germany